Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases.

Nalls MA, Bras J, Hernandez DG, Keller MF, Majounie E, Renton AE, Saad M, Jansen I, Guerreiro R, Lubbe S, Plagnol V, Gibbs JR, Schulte C, Pankratz N, Sutherland M, Bertram L, Lill CM, DeStefano AL, Faroud T, Eriksson N, Tung JY, Edsall C, Nichols N, Brooks J, Arepalli S, Pliner H, Letson C, Heutink P, Martinez M, Gasser T, Traynor BJ, Wood N, Hardy J, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC).; Parkinson's Disease meta-analysis consortium..

Neurobiol Aging. 2015 Mar;36(3):1605.e7-12. doi: 10.1016/j.neurobiolaging.2014.07.028. Epub 2014 Aug 4.

2.

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R; International Parkinson's Disease Genomics Consortium (IPDGC).; Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI).; 23andMe.; GenePD.; NeuroGenetics Research Consortium (NGRC).; Hussman Institute of Human Genomics (HIHG).; Ashkenazi Jewish Dataset Investigator.; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE).; North American Brain Expression Consortium (NABEC).; United Kingdom Brain Expression Consortium (UKBEC).; Greek Parkinson's Disease Consortium.; Alzheimer Genetic Analysis Group., Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB.

Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27.

3.

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium..

Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687.

4.

Copy number variation in familial Parkinson disease.

Pankratz N, Dumitriu A, Hetrick KN, Sun M, Latourelle JC, Wilk JB, Halter C, Doheny KF, Gusella JF, Nichols WC, Myers RH, Foroud T, DeStefano AL; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories..

PLoS One. 2011;6(8):e20988. doi: 10.1371/journal.pone.0020988. Epub 2011 Aug 2.

5.

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T; Parkinson Study Group-PROGENI Investigators..

BMC Med Genet. 2010 Apr 1;11:53. doi: 10.1186/1471-2350-11-53.

6.

Genomewide association study for onset age in Parkinson disease.

Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, Halter C, Gusella JF, Nichols WC, Myers RH, Foroud T; PROGENI Investigators, Coordinators and Molecular Genetic Laboratories.; GenePD Investigators, Coordinators and Molecular Genetic Laboratories..

BMC Med Genet. 2009 Sep 22;10:98. doi: 10.1186/1471-2350-10-98.

7.

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators..

Neurology. 2009 Jul 28;73(4):279-86. doi: 10.1212/WNL.0b013e3181af7a33.

8.

Variation in GIGYF2 is not associated with Parkinson disease.

Nichols WC, Kissell DK, Pankratz N, Pauciulo MW, Elsaesser VE, Clark KA, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators..

Neurology. 2009 Jun 2;72(22):1886-92. doi: 10.1212/01.wnl.0000346517.98982.1b. Epub 2009 Mar 11.

9.

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ; TEMPO Open-label Study Group..

Mov Disord. 2009 Mar 15;24(4):564-73. doi: 10.1002/mds.22402.

PMID:
19086083
10.

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators..

Neurology. 2009 Jan 27;72(4):310-6. doi: 10.1212/01.wnl.0000327823.81237.d1. Epub 2008 Nov 5.

11.

Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories..

Hum Genet. 2009 Jan;124(6):593-605. doi: 10.1007/s00439-008-0582-9. Epub 2008 Nov 6.

12.

Clinical correlates of depressive symptoms in familial Parkinson's disease.

Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T; Parkinson's Study Group-PROGENI Investigators..

Mov Disord. 2008 Nov 15;23(15):2216-23. doi: 10.1002/mds.22285.

13.

Practice effects within a multiple-phase Bender administration.

Smith JD, Winnick RH.

Percept Mot Skills. 1979 Apr;48(2):439-42.

PMID:
461044
14.

INTRACELLULAR DISTRIBUTION OF CARNOSINE AND ANSERINE IN SKELETAL MUSCLE.

WINNICK RE, MOIKEHA S, WINNICK T.

J Biol Chem. 1963 Nov;238:3645-7. No abstract available.

15.

Some metabolic and enzymic experiments with alpha-fluoro-beta-alanine.

WINNICK T, WINNICK RE, BERGMAN ED.

Biochim Biophys Acta. 1963 Jan 1;69:48-58. No abstract available.

PMID:
14001206
16.

Biosynthesis of gramicidin S. II. Incorporation experiments with labeled amino acid analogs, and the amino acid activation process.

WINNICK RE, WINNICK T.

Biochim Biophys Acta. 1961 Nov 11;53:461-8. No abstract available.

PMID:
14007547
17.

Biosynthesis of gramicidin S. I. General characteristics of the process in growing cultures of Bacillus brevis.

WINNICK RE, LIS H, WINNICK T.

Biochim Biophys Acta. 1961 May 27;49:451-62. No abstract available.

PMID:
13785874
18.

Protein synthesis in skeletal muscle, with emphasis on myofibrils.

WINNICK RE, WINNICK T.

J Biol Chem. 1960 Sep;235:2657-61. No abstract available.

19.

Carnosine-anserine synthetase of muscle. III. Experiments on the mechanism of peptide bond formation.

WINNICK RE, WINNICK T.

Biochim Biophys Acta. 1960 Jan 15;37:214-20. No abstract available.

PMID:
13845280
20.

Pathways and the physiological site of anserine formation.

WINNICK T, WINNICK RE.

Nature. 1959 May 23;183(4673):1466-8. No abstract available.

PMID:
13657174

Supplemental Content

Loading ...
Support Center